FBN1 and cancer: In silico data for ovarian cancer were further validated using clinical ovarian tissue samples from patients with stage III/IV ovarian cancer, as well as both cancer and normal human ovarian epithelial cell lines Our present findings show significantly downregulated FBN1 expression in the ovarian cancer samples compared to those from healthy controls, in accord with the data noted in GEPIA.